Treating Opioid Use Disorder in Pregnancy

Description

This training provides an in-depth overview of treating opioid use disorders during pregnancy, focusing on the Great Moms program. It highlights effective treatments such as buprenorphine and methadone, explores the challenges of stigma, and underscores the importance of medication-assisted treatment (MAT) in improving maternal and infant outcomes.

Target Audience

Healthcare providers, behavioral health professionals, and support staff working with pregnant or perinatal patients managing substance use disorders.

Learning Outcomes

After completing this training, you will be able to:

1. Explain the importance of medication-assisted treatment (MAT) for pregnant individuals with opioid use disorder.
2. Differentiate between methadone and buprenorphine in treating substance use disorders during pregnancy.
3. Recognize the role of stigma in providing care to pregnant individuals with substance use disorders.
4. Implement patient-centered approaches to improve adherence to prenatal care and treatment plans.